| 25.445 -0.475 (-1.83%) | 03-05 16:00 | |||||||||||||
|
|
| Short term | ||||
| Mid term | ||||
| Targets | 6-month : | 30.73 |
1-year : | 31.6 |
| Resists | First : | 26.31 |
Second : | 27.05 |
| Pivot price | 25.9 |
|||
| Supports | First : | 25.11 | Second : | 20.89 |
| MAs | MA(5) : | 25.83 |
MA(20) : | 25.85 |
| MA(100) : | 26.9 |
MA(250) : | 25.09 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 38.5 |
D(3) : | 49.9 |
| RSI | RSI(14): 38.5 |
|||
| 52-week | High : | 29.07 | Low : | 20.69 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ FMED ] has closed above bottom band by 18.4%. Bollinger Bands are 21% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 25.77 - 25.92 | 25.92 - 26.03 |
| Low: | 24.83 - 25.03 | 25.03 - 25.2 |
| Close: | 25.14 - 25.45 | 25.45 - 25.69 |
Invests in companies that are transforming medical diagnostics, therapies, and services, from gene therapy to robotic surgery and digital health platforms.
Sun, 01 Mar 2026
Trading the Move, Not the Narrative: (FMED) Edition - Stock Traders Daily
Tue, 24 Feb 2026
FMED PE Ratio & Valuation, Is FMED Overvalued - Intellectia AI
Wed, 18 Feb 2026
(FMED) Volatility Zones as Tactical Triggers - Stock Traders Daily
Fri, 07 Nov 2025
AI Opens The Door to This Active Healthcare ETF - ETF Trends
Wed, 10 Sep 2025
Investing in the Future of Healthcare - ETF Trends
Tue, 08 Jul 2025
Exploring Key Tailwinds for Fidelity's Disruptive ETFs - ETF Trends
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |